Improving Type 2 Diabetes Care with Extended-Release Metformin: Real-Life Insights from a Physician Educational Program.

Laura MolteniGiuseppe MarelliGiona CastagnaLuciano BrambillaMaurizio AcerbisFabio AlberghinaAntonio CarpaniErika ChiavennaMaria Grazia FerliniCarmen ImpellizzeriRoberto ParediAlberto RigamontiGiuseppe RivoltaOlga Eugenia Disoteo

Published in: Endocrine, metabolic & immune disorders drug targets (2024)

In a real-life setting, an educational program for general practitioners confirmed that metformin ER reduces side effects and improves pill burden, therapeutic adherence, and patient satisfaction compared to metformin IR.

Keyphrases

patient satisfaction
quality improvement
type diabetes
healthcare
glycemic control
emergency department
primary care
palliative care
cardiovascular disease
risk factors
insulin resistance
metabolic syndrome
estrogen receptor
skeletal muscle